Cargando…

Promoter methylation of IGFBP-3 and p53 expression in ovarian endometrioid carcinoma

BACKGROUND: Insulin-like growth factor binding protein (IGFBP-3) is an antiproliferative, pro-apoptotic and invasion suppressor protein which is transcriptionally regulated by p53. Promoter methylation has been linked to gene silencing and cancer progression. We studied the correlation between IGFBP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Torng, Pao-Ling, Lin, Ching-Wei, Chan, Michael WY, Yang, Hui-Wen, Huang, Su-Cheng, Lin, Chin-Tarng
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2799391/ https://www.ncbi.nlm.nih.gov/pubmed/20003326 http://dx.doi.org/10.1186/1476-4598-8-120

Ejemplares similares

Functional promoter upstream p53 regulatory sequence of IGFBP3 that is silenced by tumor specific methylation
por: Hanafusa, Tadashi, et al.
Publicado: (2005)

Clinical implication for endometriosis associated with ovarian cancer
por: Torng, Pao-Ling
Publicado: (2017)

Sulforaphene suppressed cell proliferation and promoted apoptosis of COV362 cells in endometrioid ovarian cancer
por: Yu, Hui-Yan, et al.
Publicado: (2023)

MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma
por: Li, Hai Ming, et al.
Publicado: (2015)

Clinical features and outcomes of neck lymphatic metastasis in ovarian epithelial carcinoma
por: Chen, Chien-Wen, et al.
Publicado: (2013)

Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study
por: Zhou, Ling, et al.
Publicado: (2021)

EZH2 inhibition in ARID1A mutated clear cell and endometrioid ovarian and endometrioid endometrial cancers
por: Alldredge, Jill K., et al.
Publicado: (2017)

Genomic mutation features identify distinct BRCA-associated mutation characteristics in endometrioid carcinoma and endometrioid ovarian carcinoma
por: Cao, Canhui, et al.
Publicado: (2021)

Prognostic factors of synchronous endometrial and ovarian endometrioid carcinoma
por: Yoneoka, Yutaka, et al.
Publicado: (2018)

Testosterone-Secreting Endometrioid Ovarian Carcinoma Presenting With Hyperandrogenism
por: Rajamani, Krishnakumar, et al.
Publicado: (2022)

Differential expression of hypoxia-inducible factors related to the invasiveness of epithelial ovarian cancer
por: Shih, Ho-Jun, et al.
Publicado: (2021)

Comparative study of endometrioid borderline ovarian tumor with and without endometriosis
por: Zhang, Wen, et al.
Publicado: (2018)

Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome
por: Hollis, Robert L., et al.
Publicado: (2020)

The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas
por: Zhan, Xiangbo, et al.
Publicado: (2019)

Ovarian Carcinoid Misinterpreted as Endometrioid Adenocarcinoma in Mature Cystic Teratoma
por: Tewari, Prerna, et al.
Publicado: (2020)

Potential Functions of IGFBP-2 for Ovarian Folliculogenesis and Steroidogenesis
por: Spitschak, Marion, et al.
Publicado: (2018)

IGFBP7 is associated with poor prognosis in oesophageal adenocarcinoma and is regulated by promoter DNA methylation
por: Smith, E, et al.
Publicado: (2014)

A case of ovarian yolk sac tumor associated with endometrioid adenocarcinoma
por: Koi, Chiho, et al.
Publicado: (2014)

Identification of novel cyclin gene fusion transcripts in endometrioid ovarian carcinomas
por: Agostini, Antonio, et al.
Publicado: (2018)

Prognostic analysis for Chinese patients with stage I ovarian endometrioid carcinoma
por: Zhao, Yu, et al.
Publicado: (2017)

Progesterone reduces cell survival in primary cultures of endometrioid ovarian cancer
por: Pedernera, Enrique, et al.
Publicado: (2019)

Pretreatment with LCK inhibitors chemosensitizes cisplatin‐resistant endometrioid ovarian tumors
por: Crean-Tate, Katie K., et al.
Publicado: (2021)

Integrated molecular characterisation of endometrioid ovarian carcinoma identifies opportunities for stratification
por: Hollis, Robert L., et al.
Publicado: (2021)

Primary ovarian endometrioid stromal sarcoma presenting with reno-ureteral colic
por: Moral, Ana Isabel Bueno, et al.
Publicado: (2022)

Promotion of the occurrence of endometrioid carcinoma by S100 calcium binding protein P
por: Zhang, Dan, et al.
Publicado: (2020)

PKNOX2 suppresses gastric cancer through the transcriptional activation of IGFBP5 and p53
por: Zhang, Li, et al.
Publicado: (2019)

Synchronous occurrence of primary right ovarian endometrioid adenocarcinoma and primary left ovarian clear cell adenocarcinoma: A case report
por: Zhao, Ling-jun, et al.
Publicado: (2018)

Progression Free Survival, Overall Survival, and Relapse Rate in Endometrioid Ovarian Cancer and Synchronous Endometrial-Ovarian Endometrioid Cancer (SEO-EC): Results from a Large Retrospective Analysis
por: Pecorino, Basilio, et al.
Publicado: (2022)

Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas
por: Jamieson, Amy, et al.
Publicado: (2023)

Dedifferentiated endometrioid adenocarcinoma of the uterus: A case series and review of literature
por: Goh, C., et al.
Publicado: (2020)

Phosphatase and Tensin Homolog Immunohistochemical Expression and Promoter Methylation Status in Endometrioid Endometrial Carcinoma and Its Precursor Lesions
por: Yadav, Sunita, et al.
Publicado: (2022)

Safety and fertility outcomes after the conservative treatment of endometrioid borderline ovarian tumours
por: Jia, Shuang-zheng, et al.
Publicado: (2018)

A case of ovarian endometrioid adenocarcinoma with yolk sac differentiation and Lynch syndrome
por: Sookram, Janhvi, et al.
Publicado: (2019)

Four cases of endometrioid borderline ovarian tumour: case reports and literature review
por: Nakagawa, Eriko, et al.
Publicado: (2017)

A Review of the Clinical Characteristics and Novel Molecular Subtypes of Endometrioid Ovarian Cancer
por: Chen, Shuangfeng, et al.
Publicado: (2021)

Mast Cell Tryptase and Carboxypeptidase A3 in the Formation of Ovarian Endometrioid Cysts
por: Atiakshin, Dmitri, et al.
Publicado: (2023)

Elevated Sodium Pump α3 Subunit Expression Promotes Colorectal Liver Metastasis via the p53-PTEN/IGFBP3-AKT-mTOR Axis
por: Wu, Di, et al.
Publicado: (2021)

Sema3E/Plexin-D1 Mediated Epithelial-to-Mesenchymal Transition in Ovarian Endometrioid Cancer
por: Tseng, Chun-Hsien, et al.
Publicado: (2011)

DNA methylation modifier LSH inhibits p53 ubiquitination and transactivates p53 to promote lipid metabolism
por: Chen, Ling, et al.
Publicado: (2019)

Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas.
por: Tapper, J., et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_00p15gr85sssiain9gdkqmr6cv